Healthcare
Phio Pharma
Recorded March 18, 2026
Phio Pharmaceuticals (NASDAQ: PHIO) has developed a differentiated, precision approach to treating skin cancer.
Phio Pharmaceuticals (NASDAQ: PHIO) has developed a differentiated, precision approach to treating skin cancer.
Xgene is using its proprietary conjugate platform technology to provide highly effective non-opioid relief for acute and chronic pain
Xgene is using its proprietary conjugate platform technology to provide highly effective non-opioid relief for acute and chronic pain
Coretag has built a patented Tumor Necrosis Targeting Platform to precisely guide radiotherapeutics for the treatment of many solid cancers.
Coretag has built a patented Tumor Necrosis Targeting Platform to precisely guide radiotherapeutics for the treatment of many solid cancers.
A precision neuroscience company developing treatments for children with epilepsy, autism, and other severe neurodevelopmental disorders
A precision neuroscience company developing treatments for children with epilepsy, autism, and other severe neurodevelopmental disorders
Phio Pharmaceuticals (NASDAQ: PHIO) has developed a differentiated, precision approach to treating skin cancer.
Phio Pharmaceuticals (NASDAQ: PHIO) has developed a differentiated, precision approach to treating skin cancer.
Xgene is using its proprietary conjugate platform technology to provide highly effective non-opioid relief for acute and chronic pain
AvenCell Therapeutics is pioneering the next generation of cancer treatment with powerful, persistent, and switchable allogeneic CAR-T therapies
Boost Fertility is on a mission to ensure clinical-grade infertility treatment is affordable and available for anyone who wants it.